Skip to content

An open label clinical trial to evaluate the efficacy of Vamana Karma ( Emesis) in the management of Urdhwaga Amalpitta (Hyperacidity and Gastritis ).â??

An open label clinical trial to evaluate the efficacy of Vamana Karma in the management of Urdhwaga Amalpitta.â??

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050890
Enrollment
30
Registered
2023-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K290- Acute gastritis

Interventions

None listed

Sponsors

Shri Krishna Government Ayurvedic College and Hospital kurukshetra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical sign and symptoms of Urdhwaga Amlapitta as per Ayurvedic classics. 2. Patient having cardinal symptoms of gastritis and hyperacidity with the duration not more than one year. 3. Male or female between the age group 25- 50 year. 4. Patients who are fit for Vaman Karma as per ayurvedic classics.

Exclusion criteria

Exclusion criteria: 1. Patients below 25 years and above 50 years. 2. Patients of Amlapitta with any chronic system disease which interferes with the present study. 3. Patients suffering from any current acute illness. 4. Patients having associated complicated systemic disorders like cardiac diseases, diabetes, tuberculosis, bronchial asthma, autoimmune diseases etc. 5. Known case of gastric and duodenal ulcer. 6. Known case of gastric carcinoma. 7. Chronic gastritis (more than one year) 8. Hiatus hernia, Barrettâ??s esophagus. 9. Patients with the previous history of hematemesis, hemoptysis or melena. 10. Patients having congenital physiological anomalies, surgical interventions, and any trauma. 11. Patients who are contraindicated for Vaman Karma.

Design outcomes

Primary

MeasureTime frame
primary outcome Relieve in the sign and symptoms of Urdhwaga Amlapitta as per subjective criteria Timepoint: at the baseline of 20th 40th & 60th day

Secondary

MeasureTime frame
â?¢ The lifestyle of patient improved after the treatment. Patient can perform daily routine activity without any trouble. â?¢ He/she can enjoy the food and lifestyle of his/her choice.Timepoint: at the baseline of within or after the 60th day.

Countries

India

Contacts

Public ContactNeetu chauhan

Shri krishna gov. ayurvedic college and hospital kurukshetra haryana

drashishhmehta@gmail.com9468319930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026